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Re: Schaffer JM, Singh SK, Reitz BA, Oyer PE, Robbins RC, Mallidi HR. Heart transplant graft survival is improved after
a reduction in panel reactive antibody activity. J Thorac Cardiovasc Surg. 2013;145:555-65.
In Figure 4 of the above-mentioned article, the 2 Kaplan-Meier curves were mislabeled: The curve for the patients who had
a substantial panel reactive antibody reduction was labeled as the curve for patients who had a trivial panel reactive antibody
reduction and vice versa. The corrected version of the figure is printed below.y c Volume 145, Number 5 1419
